AlzeCure’s ACD856 research shows positive impact on brain
Exploratory central nervous system analysis shows that ACD856 increases activity in brain
Read MoreExploratory central nervous system analysis shows that ACD856 increases activity in brain
Read MoreStudy reveals first genetic links in chronic fatigue syndrome, paving the way for new drugs
Read MoreTherapy is for the treatment of spasticity due to multiple sclerosis
Read MoreModelling indicates a 307% increase in cases identified between 2020 and 2021
Read MoreUp-LIFT research achieves primary endpoint with improvement in arm and hand function
Read More




PharmaTimes Media Ltd.
44 Maiden Lane
Covent Garden
London
WC2E 7LN
E: editorial@pharmatimes.com
E: subscriptions@pharmatimes.com
T: +44 (0)20 7240 6999
